Unity Biotechnology Inc (STU:9U90)

€ 1.308 -0.008 (-0.61%) Market Cap: 22.57 Mil Enterprise Value: 9.93 Mil PE Ratio: 0 PB Ratio: 0.98 GF Score: 30/100

UNITY Biotechnology Inc at HC Wainwright Ophthalmology Virtual Conference Transcript
Aug 16, 2023
UNITY Biotechnology Inc Annual Shareholders Meeting Transcript
Jun 23, 2023
UNITY Biotechnology Inc To Discuss The Most Recent UBX1325 Clinical Data Call Transcript
Apr 24, 2023
UNITY Biotechnology Inc To Discuss Phase 2 ENVISION Program Update Call Transcript
Mar 27, 2023
UNITY Biotechnology Inc at Cowen Health Care Conference Transcript
Mar 07, 2023
UNITY Biotechnology Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Feb 15, 2023
UNITY Biotechnology Inc KOL Call Transcript
Feb 14, 2023
UNITY Biotechnology Inc To Discuss Phase 2 BEHOLD Program Update Call Transcript
Nov 01, 2022
UNITY Biotechnology Inc Analyst Day Transcript
Oct 12, 2022
UNITY Biotechnology Inc To Discuss Lead Program UBX1325 Call Transcript
Aug 12, 2022
UNITY Biotechnology Inc Annual Shareholders Meeting Transcript
Jun 24, 2022
UNITY Biotechnology Inc at UBS Global Healthcare Conference Transcript
May 25, 2022
UNITY Biotechnology Inc At KOL Webinar Call Transcript
Nov 09, 2021
UNITY Biotechnology Inc To Discuss The Most Recent UBX1325 Clinical Data Call Transcript
Oct 05, 2021
UNITY Biotechnology Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
UNITY Biotechnology Inc To Discuss The UBX1325 Clinical Data Call Transcript
Jul 27, 2021
UNITY Biotechnology Inc Corporate Call Transcript
Jul 06, 2021
UNITY Biotechnology Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 03, 2021
UNITY Biotechnology Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2020
Unity Biotechnology, Inc. - Special Call Transcript
Aug 17, 2020
UNITY Biotechnology Inc Annual Shareholders Meeting Transcript
Jun 18, 2020
UNITY Biotechnology Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 11, 2020
UNITY Biotechnology Inc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
UNITY Biotechnology Inc to Discuss the UBX0101 Clinical Data Call Transcript
Jun 18, 2019
UNITY Biotechnology Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019

UNITY Biotechnology Inc To Discuss The UBX1325 Clinical Data Call Transcript

Jul 27, 2021 / 03:00PM GMT

Release Date Price: €31.38 (-0.25%)

Transcript 10-Q8-K

Operator

Good day, and thank you for standing by. Welcome to the Unity Biotechnology KOL Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Lynne Sullivan, Chief Financial Officer. Please go ahead.

Lynne Marie Sullivan

Unity Biotechnology, Inc. - CFO & Head of Corporate Development

Good morning. Thank you for joining Unity Biotechnology's conference call this morning to discuss the Phase I results from our UBX1325 program. With me on today's call is Robert Bhisitkul, Professor of Ophthalmology and Director of the Retina Fellowship at University of California San Francisco, a renowned retinal specialist; Anirvan Ghosh, the CEO of Unity Biotechnology; Jamie Dananberg, the Chief Medical Officer of Unity Biotechnology; and myself, Lynne Sullivan, the Chief Financial Officer.

Before turning the call over to Anirvan, I'd like to remind you that during today's call, we'll be making some forward-looking

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.